BALL KRISTINE M
Insider CIK 1266163 · RLYP Chief Financial Officer & SVP · BCEL Director · MNLO See Remarks · FTSV Director · ELVN Director · ORKA Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ELVN Enliven Therapeutics, Inc. | A Award deriv | 2026-10-14 | 2026-10-16 | 23,394 | — | $0 | 23,394 | SEC↗ |
| ORKA Oruka Therapeutics, Inc. | A Award deriv | 2026-06-02 | 2026-06-03 | 9,136 | — | $0 | 9,136 | SEC↗ |
| ORKA Oruka Therapeutics, Inc. | A Award deriv | 2025-06-02 | 2025-06-03 | 17,500 | — | $0 | 17,500 | SEC↗ |
| BCEL Atreca, Inc. | A Award deriv | 2023-06-13 | 2023-06-15 | 12,000 | — | $0 | 12,000 | SEC↗ |
| BCEL Atreca, Inc. | A Award deriv | 2022-06-08 | 2022-06-10 | 12,000 | — | $0 | 12,000 | SEC↗ |
| BCEL Atreca, Inc. | A Award deriv | 2021-06-09 | 2021-06-11 | 12,000 | — | $0 | 12,000 | SEC↗ |
| BCEL Atreca, Inc. | A Award deriv | 2020-06-10 | 2020-06-15 | 12,000 | — | $0 | 12,000 | SEC↗ |
| BCEL Atreca, Inc. | A Award deriv | 2020-05-20 | 2020-05-21 | 24,000 | — | $0 | 24,000 | SEC↗ |
| FTSV Forty Seven, Inc. | D To issuer deriv | 2020-04-07 | 2020-04-07 | 10,322 | — | $0 | 0 | SEC↗ |
| FTSV Forty Seven, Inc. | D To issuer deriv | 2020-04-07 | 2020-04-07 | 69,677 | — | $0 | 0 | SEC↗ |
| MNLO Menlo Therapeutics Inc. | M Exercise deriv | 2019-12-11 | 2019-12-16 | 80,300 | — | $0 | 0 | SEC↗ |
| MNLO Menlo Therapeutics Inc. | M Exercise | 2019-12-11 | 2019-12-13 | 80,300 | — | $0 | 80,300 | SEC↗ |
| MNLO Menlo Therapeutics Inc. | F Tax w/h | 2019-12-11 | 2019-12-13 | 27,766 | $4.52 | $125.5K | 52,534 | SEC↗ |
| MNLO Menlo Therapeutics Inc. | F Tax w/h | 2019-12-11 | 2019-12-16 | 27,766 | $4.52 | $125.5K | 52,534 | SEC↗ |
| MNLO Menlo Therapeutics Inc. | M Exercise | 2019-12-11 | 2019-12-16 | 80,300 | — | $0 | 80,300 | SEC↗ |
| MNLO Menlo Therapeutics Inc. | A Award deriv | 2019-07-29 | 2019-07-31 | 80,300 | — | $0 | 413,423 | SEC↗ |
| MNLO Menlo Therapeutics Inc. | A Award deriv | 2019-07-29 | 2019-08-07 | 80,300 | — | $0 | 413,423 | SEC↗ |
| FTSV Forty Seven, Inc. | A Award deriv | 2019-06-12 | 2019-06-14 | 10,322 | — | $0 | 10,322 | SEC↗ |
| MNLO Menlo Therapeutics Inc. | A Award deriv | 2018-12-10 | 2018-12-12 | 96,000 | — | $0 | 96,000 | SEC↗ |
| MNLO Menlo Therapeutics Inc. | A Award deriv | 2018-05-03 | 2018-05-04 | 64,000 | — | $0 | 237,123 | SEC↗ |
| RLYP Relypsa Inc | D To issuer deriv | 2016-09-01 | 2016-09-02 | 25,000 | — | $0 | 0 | SEC↗ |
| RLYP Relypsa Inc | D To issuer deriv | 2016-09-01 | 2016-09-02 | 122,872 | — | $0 | 0 | SEC↗ |
| RLYP Relypsa Inc | D To issuer deriv | 2016-09-01 | 2016-09-02 | 43,603 | — | $0 | 0 | SEC↗ |
| RLYP Relypsa Inc | D To issuer deriv | 2016-09-01 | 2016-09-02 | 35,000 | — | $0 | 0 | SEC↗ |
| RLYP Relypsa Inc | D To issuer deriv | 2016-09-01 | 2016-09-02 | 38,500 | — | $0 | 0 | SEC↗ |
| RLYP Relypsa Inc | A Award deriv | 2016-09-01 | 2016-09-02 | 16,667 | — | $0 | 25,000 | SEC↗ |
| RLYP Relypsa Inc | D To issuer | 2016-09-01 | 2016-09-02 | 20,355 | $32.00 | $651.4K | 0 | SEC↗ |
| RLYP Relypsa Inc | A Award | 2016-09-01 | 2016-09-02 | 4,167 | — | $0 | 32,277 | SEC↗ |
| RLYP Relypsa Inc | U Tender | 2016-09-01 | 2016-09-02 | 11,922 | $32.00 | $381.5K | 20,355 | SEC↗ |
| RLYP Relypsa Inc | F Tax w/h | 2016-08-15 | 2016-08-17 | 1,480 | $31.89 | $47.2K | 28,110 | SEC↗ |
| RLYP Relypsa Inc | A Award deriv | 2016-06-03 | 2016-06-07 | 8,333 | — | $0 | 8,333 | SEC↗ |
| RLYP Relypsa Inc | F Tax w/h | 2016-06-03 | 2016-06-07 | 783 | $19.96 | $15.6K | 29,590 | SEC↗ |
| RLYP Relypsa Inc | A Award | 2016-06-03 | 2016-06-07 | 2,083 | — | $0 | 30,373 | SEC↗ |
| RLYP Relypsa Inc | P Buy | 2016-03-16 | 2016-03-16 | 7,000 | $12.15 | $85.0K | 28,290 | SEC↗ |
| RLYP Relypsa Inc | A Award | 2015-11-06 | 2015-11-10 | 6,250 | — | $0 | 21,290 | SEC↗ |
| RLYP Relypsa Inc | S Sale | 2015-09-02 | 2015-09-03 | 646 | $22.96 | $14.8K | 15,040 | SEC↗ |
| RLYP Relypsa Inc | S Sale | 2015-08-17 | 2015-08-19 | 710 | $24.78 | $17.6K | 15,040 | SEC↗ |
| RLYP Relypsa Inc | A Award deriv | 2015-08-10 | 2015-08-12 | 38,500 | — | $0 | 38,500 | SEC↗ |
| RLYP Relypsa Inc | A Award | 2015-08-10 | 2015-08-12 | 8,250 | — | $0 | 15,750 | SEC↗ |
| RLYP Relypsa Inc | M Exercise deriv | 2015-03-05 | 2015-03-05 | 3,000 | — | $0 | 122,872 | SEC↗ |
| RLYP Relypsa Inc | M Exercise | 2015-03-05 | 2015-03-05 | 3,000 | $3.96 | $11.9K | 10,500 | SEC↗ |
| RLYP Relypsa Inc | S Sale | 2015-03-05 | 2015-03-05 | 3,000 | $41.00 | $123.0K | 7,500 | SEC↗ |
| RLYP Relypsa Inc | S Sale | 2015-03-03 | 2015-03-05 | 519 | $38.80 | $20.1K | 7,500 | SEC↗ |
| RLYP Relypsa Inc | M Exercise deriv | 2015-01-21 | 2015-01-23 | 3,000 | — | $0 | 125,872 | SEC↗ |
| RLYP Relypsa Inc | S Sale | 2015-01-21 | 2015-01-23 | 3,000 | $36.00 | $108.0K | 7,500 | SEC↗ |
| RLYP Relypsa Inc | M Exercise | 2015-01-21 | 2015-01-23 | 3,000 | $3.96 | $11.9K | 10,500 | SEC↗ |
| RLYP Relypsa Inc | A Award deriv | 2014-08-14 | 2014-08-18 | 35,000 | — | $0 | 35,000 | SEC↗ |
| RLYP Relypsa Inc | A Award | 2014-08-14 | 2014-08-18 | 7,500 | — | $0 | 7,500 | SEC↗ |